At Fortis Healthcare Singapore, patients and their families can expect thoughtful care, comfort and dedication.

Fortis Healthcare Singapore is part of the Fortis Healthcare family founded in 2001, which today has a presence in various geographies across multiple healthcare verticals - from hospitals, specialist clinics, primary care facilities, laboratories to imaging centres. Tapping into Singapore’s status as a leading medical hub, we aim to enhance patient care throughout the region with innovative research and partnership models, to give patients access to comprehensive, integrated specialty care.

Drawing on our rich heritage of global experience spanning the entire spectrum of healthcare, FHS aims to bring our medical expertise to benefit the medical community through its entities in Singapore - Fortis Surgical Hospital, Radlink-Asia Pte Ltd and Singapore Radiopharmaceuticals.

Patient Centricity sits at the heart of what we do.

Fortis Surgical Hospital (FSH) brings together the expertise of renowned surgeons in the delivery of advanced surgical procedures in Colorectal, Urology, Gynaecology, Plastic and General Surgeries. Specific to advanced minimally invasive surgery, FSH offers the full spectrum of advanced surgical procedures including laparoscopic and robotic-assisted techniques. Also housed within FSH are our outpatient facilities which include a 24-Hour Outpatient Clinic, a Specialist Clinic, a Wellness Centre dedicated to health screening, and in-house x-ray, ultrasound and CT radiology services.

Our Facilities:

  • 24-Hours Outpatient Clinic
  • Specialist Clinic
  • Health Screening Centre
  • Radiology

Click here to visit the Fortis Surgical Hospital home page.

Comfort. Care. Connect.

Singapore’s largest provider of outpatient diagnostic imaging, nuclear medicine and leading radiopharmaceuticals.

Click here to visit the RadLink home page.

Future Imaging Solutions

Singapore Radiopharmaceuticals is the first company in the region to manufacture an imaging biomarker for Parkinson’s disease.

New products will soon be available from Singapore Radiopharmaceuticals to the clinical research community enabling neurological studies investigating diseases that produce inflammation in the brain.

Future collaboration with pharmaceuticals companies will provide access to proprietary products that can image processes related to diseases such as dementia.

Click here to visit the Singapore Radiopharmaceuticals home page.